D.A. Davidson & Co’s Array Biopharma Inc ARRY Stock Holding History

D.A. Davidson & Co’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-294	Closed	-$2K	–	2240
2017 Q2	$2K	Hold	294	–	–	﹤0.01%	2310
2017 Q1	$2K	Hold	294	–	–	﹤0.01%	2281
2016 Q4	$2K	Hold	294	–	–	﹤0.01%	2372
2016 Q3	$1K	Hold	294	–	–	﹤0.01%	2357
2016 Q2	$1K	Hold	294	–	–	﹤0.01%	2312
2016 Q1	$0	Hold	294	–	–	﹤0.01%	2383
2015 Q4	$1K	Hold	294	–	–	﹤0.01%	2196
2015 Q3	$1K	Hold	294	–	–	﹤0.01%	2167
2015 Q2	$2K	Hold	294	–	–	﹤0.01%	2134
2015 Q1	$2K	Hold	294	–	–	﹤0.01%	2018
2014 Q4	$1K	Hold	294	–	–	﹤0.01%	2074
2014 Q3	$1K	Hold	294	–	–	﹤0.01%	2082
2014 Q2	$1K	Hold	294	–	–	﹤0.01%	2072
2014 Q1	$1K	Sell	294 -685	-70%	-$3.44K	﹤0.01%	2077
2013 Q4	$4K	Buy	+979	New	+$5.33K	﹤0.01%	1908

Other funds holding ARRY

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return